On the other hand, YAP1 fusion-positive ependymomas account for only 6%–7.4% of all pediatric supratentorial ependymomas and are restricted to young children, with a male:female ratio of 0.3:1 (98). This evidence concerns the gene YAP1 and ependymoma.